From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out and who I spoke with to break it all down.
T1D travel tips, insulin packing advice, and real-world stories from long-term travelers—plus links to our ultimate diabetes travel guide and expert educator insights.
From tubeless patch pumps to fully closed-loop systems, here’s a look at the next generation of insulin pump innovation—and the companies leading the charge.
A new CGM deal moves PharmaSens one step closer to creating a fully self-contained insulin pump and CGM.
With seamless site changes and fast software iteration, Beta Bionics’ upcoming patch pump could challenge the pace and expectations of the tubeless pump market.
The pump currently in development allows users to change sites without a phone—potentially reshaping the tubeless landscape and pushing rivals to move faster.
My Diabetes Educator shares expert tips for traveling confidently with diabetes, from packing to navigating air travel and insulin treatment on vacation.
Smartwatch bolusing, advanced occlusion detection, and CGM integration set the stage for Sequel Med Tech’s game-changing debut.
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
After hearing your stories, we brought in experts—and spoke to Dexcom—to unpack what’s going on with Dexcom G7 sensor failures.
Dexcom's latest CGM is now supported on the Omnipod 5 iPhone App.
